Pune: Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca COVID-19 vaccine ‘Covishield’ is ready to roll out in the coming weeks. Also Read - PM Modi Congratulates India as Two COVID-19 Vaccines Get Clearance For Emergency Use
Poonawalla’s remarks came soon after after India’s drugs regulator approved Covishield for restricted emergency use. Also Read - Covishield of Serum Institute, Covaxin of Bharat Biotech Get DCGI Approval As Coronavirus Vaccines
“Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India’s first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks,” Poonawalla tweeted. Also Read - The Wait Is Over, Approval Of 2 Coronavirus Vaccines Paves Way For Mass Rollout In India | All We Know
“Thank you Hon. Sri @narendramodi Ji, Hon. Sri @drharshvardhan Ji, @MoHFW_INDIA @ICMRDELHI @DBTIndia #DCGI_India @UniofOxford @AstraZeneca @gavi @GaviSeth @gatesfoundation and @BillGates for your support,” he added.